Speak to a
    2.5 iPAAG expert

    Contura | Hydrogels for life
    • OUR Technology
      • Our Science
      • Our Facility
    • Our Therapeutic areas
      • Orthopaedics
      • Animal Health
      • Urinary Incontinence
    • Our Story
      • About Us
      • History
      • Team
    • Contact us
    • Careers

    Category: Contura

    CONTURA ANNOUNCES NEW CEO TO ACCELERATE FUTURE GROWTH

    Posted on 17 November 2021 | by Podymos | Leave a Comment on CONTURA ANNOUNCES NEW CEO TO ACCELERATE FUTURE GROWTH

    Contura sells Bulkamid® to Axonics Modulation Technologies, Inc

    Posted on 26 February 2021 | by Podymos | Leave a Comment on Contura sells Bulkamid® to Axonics Modulation Technologies, Inc

    Contura expands its commercial efforts to the US and appoints new US Leadership Team

    Posted on 10 February 2020 | by Podymos | Leave a Comment on Contura expands its commercial efforts to the US and appoints new US Leadership Team

    Acquisition of Manufacturing Facility in Copenhagen, Denmark

    Posted on 25 May 2018 | by Podymos | Leave a Comment on Acquisition of Manufacturing Facility in Copenhagen, Denmark

    Speciality European Pharma Limited to rebrand as Contura in order to consolidate its corporate structure and drive growth

    Posted on 19 January 2018 | by Podymos | Leave a Comment on Speciality European Pharma Limited to rebrand as Contura in order to consolidate its corporate structure and drive growth

    Speciality European Pharma sells Mitem to Substipharm Limited

    Posted on 27 April 2017 | by Podymos | Leave a Comment on Speciality European Pharma sells Mitem to Substipharm Limited

    MBO at SEP provides capital to accelerate growth and expansion

    Posted on 1 May 2016 | by Podymos | Leave a Comment on MBO at SEP provides capital to accelerate growth and expansion

    Speciality European Pharma acquires Contura A/S

    Posted on 30 April 2013 | by Podymos | 1 Comment on Speciality European Pharma acquires Contura A/S

    Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

    Recent Posts

    • New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS
    • First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis
    • Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner
    • First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis
    • BASK-ing-IN-THE-GLORY-OF-SUCCESSFUL-SEMINAR-AT-LEADING-ORTHOPAEDIC-CONFERENCE-WITH-PATIENT-OUTCOMES-AT-ITS-HEART.pdf

    Recent Comments

    • A WordPress Commenter on Speciality European Pharma acquires Contura A/S

    Archives

    • September 2023
    • August 2023
    • June 2023
    • April 2023
    • December 2022
    • October 2022
    • November 2021
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • June 2019
    • May 2018
    • January 2018
    • July 2017
    • April 2017
    • February 2017
    • December 2016
    • May 2016
    • September 2015
    • July 2015
    • December 2014
    • May 2013
    • April 2013

    Categories

    • Arthramid Vet
    • Arthrosamid
    • Bulkamid
    • Contura

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    *2.5 iPAAG is an injectable polyacrylamide hydrogel known for its unique
    composition, comprising of 2.5% cross-linked polyacrylamide and 97.5% water.

    Arthrosamid is a registered trademark of Contura International A/S.
    Contura Vet is a registered trademark of Contura Vet Ltd.
    Privacy Notice
    © copyright 2025 Contura International Ltd.

    We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

    I accept My Preferences